Council for International Organizations of Medical Sciences, Geneva, 27-28 October 1998: Definitions and Basic Requirements for the Use of Terms for Reporting Adverse Drug Reactions (XIII): Clinical Pathology and General Disorders

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue 3, 1999, Pages 217-224

  Aellig, W ^a   Bankowski, Z ^a   Bruppacher, R ^a   Crusius, I ^a   Gallagher, J ^a   Gratwohl, A ^a   Idanpaan Heikkila, J E ^a   Kreft Jais, C ^a   Kremer, G ^a   Laurell, G ^a   Mann, R D ^a   Spiegl, W ^a   Stoller, R ^a   Venulet, J ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Aggravated exacerbated; Anaemia; Anaemia aplastic; Anaemia haemolytic; Anaemia hypochromic microcytic; Anaphylactic reaction; Anaphylactic shock; Anaphylactoid reaction; Asthenia; Dehydration; Gout; Hypovolaemia; Malaise; Ototoxicity; Pancytopenia; Rigors; Withdrawal syndrome

Indexed keywords

ADVERSE DRUG REACTION; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANEMIA; APLASTIC ANEMIA; ASTHENIA; CONFERENCE PAPER; DEHYDRATION; DISEASE CLASSIFICATION; GOUT; HEMOLYTIC ANEMIA; HYPOVOLEMIA; MALAISE; MEDICINE; NOMENCLATURE; ORGANIZATION; OTOTOXICITY; PANCYTOPENIA; PATHOLOGY; PRIORITY JOURNAL; RIGOR; SWITZERLAND; WITHDRAWAL SYNDROME;

EID: 0032991206     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199905/06)8:3<217::AID-PDS415>3.0.CO;2-Q     Document Type: Conference Paper

References (15)

1. International Reporting of Adverse Drug Reactions. Final Report of CIOMS Working Group, CIOMS, Geneva, 1990.
2. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an International Consensus Meeting. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990; 28(8): 317-322.
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29(2): 75-81.
4. Basic requirements for the use of terms for reporting adverse drug reactions. Anaphylactic shock, arrhythmia, cardiac failure, hypertension, thrombosis and embolism. Pharmacoepidemiol. Drug Saf. 1992; 1: 39-45.
5. Basic requirements for the use of terms for reporting adverse drug reactions (II). Colitis, gastrointestinal haemorrhage, hepatocellular damage, peptic ulcer, pancreatitis. Pharmacoepidemiol. Drug Saf. 1992; 1: 133-137.
6. Basic requirements for the use of terms for reporting adverse drug reactions (III). Aplastic anaemia, bone marrow depression, coagulation disorders, agranulocytosis, thrombophlebitis. Pharmacoepidemiol. Drug Saf. 1992; 1: 191-196.
7. Basic requirements for the use of terms for reporting adverse drug reactions (IV). Dyskinesia, depression, myopathy, neuropathy, paralysis, convulsions. Pharmacoepidemiol. Drug Saf. 1993; 2: 149-153.
8. Basic requirements for the use of terms for reporting adverse drug reactions (V). Vision abnormal, keratitis, cataract, retinal disorder, acidosis. Pharmacoepidemiol. Drug Saf. 1993; 2: 189-193.
9. Definitions of adverse drug reactions and minimum requirements for their use: cardiovascular disease terms. Pharmacoepidemiol. Drug Saf. 1993; 2: 591-602.
10. Harmonizing the use of adverse-drug-reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders. Pharmacoepidemiol. Drug Saf. 1997; 6: 115-127.
11. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): Renal and urinary system disorders. Pharmacoepidemiol. Drug Saf. 1997; 6: 203-211.
12. Basic requirements for the use of terms for reporting adverse drug reactions (IX). Nervous system and psychiatric disorders. Pharmacoepidemiol. Drug Saf. 1998; 7: 39-49.
13. Basic requirements for the use of terms for reporting adverse drug reactions (X). Gastrointestinal system disorders. Pharmacoepidemiol. Drug Saf. 1998; 7: 281-287.
14. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): Cardiovascular system disorders. Pharmacoepidemiol. Drug Saf. 1998; 7: 351-357.
15. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): Collagen disorders and musculo-skeletal disorders. Pharmacoepidemiol. Drug Saf. 1999; 8: 141-145.